News & Media

Newport Laboratories launches ParaSail

  • by
  • Mar 07, 2012

WORTHINGTON, MN - Newport Laboratories is excited to announce the arrival of ParaSail®, the swine industry's first avirulent live, single-dose vaccine for Haemophilus parasuis.

Available exclusively through veterinarians, ParaSail has been proven to protect against three of the most predominant strains of H. parasuis currently circulating: serotype 4 (found in 25% of cases), serotype 5 (found in 15% of all cases) and serotype 13. Multiple side-by-side comparisons have showed a single dose of the vaccine to be as effective as a two-dose regime. The USDA has approved ParaSail for use as a single-dose product with a 1mL dose size, intramuscular.